Related Experiment Video
Updated: May 29, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Intrapericardial Triamcinolone Instillation for Recurrent Pericardial Effusion in Pediatric Patients: A Review of
Abhiram Reddy1, Daniel Peck1, Daniel Cortez2
1Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Masonic Children's Hospital, 2450 Riverside Ave, Academic Office Building (AOB), 4th floor, # AOB-407, Minneapolis, MN, 55454, USA.
Insights
Intrapericardial triamcinolone shows promise for treating recurrent pericardial effusion in children. This study found it effective and safe as an adjunctive therapy for pediatric patients with idiopathic pericardial effusions.
Area of Science:
- Pediatric Cardiology
- Pharmacology
- Medical Case Studies
Background:
- Recurrent pericardial effusion in children lacks extensive research regarding intrapericardial triamcinolone.
- The efficacy and safety of intrapericardial triamcinolone in pediatric patients are not well-defined.
Purpose of the Study:
- To evaluate the efficacy, side effects, and safety of intrapericardial triamcinolone in pediatric patients with recurrent idiopathic pericardial effusions.
- To expand the understanding of this treatment in a pediatric population.
Main Methods:
- Retrospective case series of nine pediatric patients treated with intrapericardial triamcinolone.
- Data collected from 2015 to 2025 at a single center.
- Efficacy assessed via echocardiograms and symptom monitoring; side effects documented.
Main Results:
- Five patients achieved resolution of pericardial effusion; three showed improvement.
- One patient experienced relapse; five had transient, steroid-like side effects.
- Two patients died due to underlying conditions, not treatment.
Conclusions:
- Intrapericardial triamcinolone appears to be a safe and effective adjunctive treatment for pediatric recurrent idiopathic pericardial effusion.
- Further research is warranted to fully characterize its long-term outcomes and safety profile in children.
Abstract:
Intrapericardial administration of the glucocorticoid medication triamcinolone is reported useful in the treatment of recurrent pericardial effusion in adult patients. Nevertheless, the studies on triamcinolone use in pediatric patients are scarce, and the effectiveness and side effect profile of intrapericardial triamcinolone in children is not well characterized. This single center retrospective case series seeks to expand on the efficacy, side effects, and safety of intrapericardial triamcinolone in pediatric patients suffering from recurrent idiopathic pericardial effusions. Nine pediatric patients who received intrapericardial triamcinolone for recurrent idiopathic pericardial effusion at a single center from 2015 to 2025 were included. The pericardial effusion progression was observed with serial echocardiograms and new symptoms appeared after triamcinolone administration. Five patients demonstrated resolution of pericardial effusion, three had improvement, and one relapsed after intrapericardial triamcinolone administration. Five patients suffered from short-term steroid-like side effects that resolved prior to discharge, and two died of underlying disease rather than treatment with triamcinolone. These findings are consistent with the idea that intrapericardial triamcinolone can be utilized as a safe and effective adjunctive treatment option in children with recurrent idiopathic pericardial effusion.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Pericarditis IV: Nursing Management
Myocarditis III: Medical Management
Mitral Stenosis III: Medical Management
